Meta‐analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test

A variety of tests have been proposed for colorectal cancer (CRC), giving rise to uncertainty regarding the optimal approach. The efficacy and effectiveness of different tests are related to both screenee participation and the detection rate.

[1]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[2]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[3]  J. Kleijnen,et al.  The determinants of screening uptake and interventions for increasing uptake: a systematic review. , 2000, Health technology assessment.

[4]  O. Kronborg,et al.  Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study. , 1999, Scandinavian journal of gastroenterology.

[5]  Cesare Hassan,et al.  Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[6]  J. Habbema,et al.  Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy , 2009, Gut.

[7]  J. Hardcastle,et al.  Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening , 1997, The British journal of surgery.

[8]  P. Giorgi Rossi,et al.  Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy. , 2006, Cancer detection and prevention.

[9]  N Segnan,et al.  European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Executive summary , 2012, Endoscopy.

[10]  A. Verbeek,et al.  Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. , 2008, Gastroenterology.

[11]  P. Bampton,et al.  A comparison of colorectal neoplasia screening tests: a multicentre community‐based study of the impact of consumer choice , 2006 .

[12]  G. Murata,et al.  Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. , 2010, Preventive medicine.

[13]  D. Lieberman,et al.  Clinical practice. Screening for colorectal cancer. , 2009, The New England journal of medicine.

[14]  L. Bisanti,et al.  Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. , 2007, Gastroenterology.

[15]  S. Crotta,et al.  High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  P. Bossuyt,et al.  Paper alert , 2012, Gastroenterology.

[17]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[18]  L. Bisanti,et al.  Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. , 2011, Journal of the National Cancer Institute.

[19]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  Rongwei Fu,et al.  Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[21]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[22]  Douglas K Rex,et al.  American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2022 .

[23]  Perry J Pickhardt,et al.  Value-of-information analysis to guide future research in colorectal cancer screening. , 2009, Radiology.

[24]  A. Adrain,et al.  A comparison of fecal occult-blood tests for colorectal-cancer screening. , 1996, The New England journal of medicine.

[25]  Amy B. Knudsen,et al.  Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. , 2010, Journal of the National Cancer Institute.

[26]  H. Brenner,et al.  Protection From Colorectal Cancer After Colonoscopy , 2011, Annals of Internal Medicine.

[27]  D. Moher,et al.  Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. , 2008, Annals of internal medicine.

[28]  H. Brenner,et al.  Protection from colorectal cancer after colonoscopy: Population-based case-control study , 2010 .

[29]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[30]  Y. Niv,et al.  A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study , 2011, International journal of cancer.

[31]  N. Segnan,et al.  European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Principles of evidence assessment and methods for reaching recommendations , 2012, Endoscopy.

[32]  A. Spigelman.  A comparison of colorectal neoplasia screening tests: a multicentre community‐based study of the impact of consumer choice , 2006, The Medical journal of Australia.

[33]  D. Rex,et al.  Considerations regarding the present and future roles of colonoscopy in colorectal cancer prevention. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  S. Stryker,et al.  Natural history of untreated colonic polyps. , 1987, Gastroenterology.

[35]  L. Bisanti,et al.  Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. , 2005, Journal of the National Cancer Institute.

[36]  Daniel S. Miller,et al.  The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer , 2000, Cancer.

[37]  P. Tappenden,et al.  Option appraisal of population-based colorectal cancer screening programmes in England , 2006, Gut.

[38]  P. Giorgi Rossi,et al.  The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial , 2005, Journal of medical screening.

[39]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[40]  P. Glasziou,et al.  A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. , 1998, BMJ.

[41]  Á. Lanas,et al.  Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. , 2012, The New England journal of medicine.

[42]  Cancer,et al.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.

[43]  Charles J. Kahi,et al.  Effect of screening colonoscopy on colorectal cancer incidence and mortality. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[44]  B. Levin,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.

[45]  J. Schulman,et al.  Complications of Colonoscopy in an Integrated Health Care Delivery System , 2006, Annals of Internal Medicine.